|
DE2031216A1
(de)
|
1969-06-19 |
1971-01-14 |
Citizen Watch Co Ltd , Tokio |
Tag und Datum Stellvorrichtung fur Uhren mit Kalender
|
|
US3940475A
(en)
|
1970-06-11 |
1976-02-24 |
Biological Developments, Inc. |
Radioimmune method of assaying quantitatively for a hapten
|
|
NL154598B
(nl)
|
1970-11-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
|
|
US3817837A
(en)
|
1971-05-14 |
1974-06-18 |
Syva Corp |
Enzyme amplification assay
|
|
US3939350A
(en)
|
1974-04-29 |
1976-02-17 |
Board Of Trustees Of The Leland Stanford Junior University |
Fluorescent immunoassay employing total reflection for activation
|
|
US3996345A
(en)
|
1974-08-12 |
1976-12-07 |
Syva Company |
Fluorescence quenching with immunological pairs in immunoassays
|
|
US4277437A
(en)
|
1978-04-05 |
1981-07-07 |
Syva Company |
Kit for carrying out chemically induced fluorescence immunoassay
|
|
US4275149A
(en)
|
1978-11-24 |
1981-06-23 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
|
US4366241A
(en)
|
1980-08-07 |
1982-12-28 |
Syva Company |
Concentrating zone method in heterogeneous immunoassays
|
|
US4957939A
(en)
|
1981-07-24 |
1990-09-18 |
Schering Aktiengesellschaft |
Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
|
|
US4472509A
(en)
|
1982-06-07 |
1984-09-18 |
Gansow Otto A |
Metal chelate conjugated monoclonal antibodies
|
|
US4588585A
(en)
|
1982-10-19 |
1986-05-13 |
Cetus Corporation |
Human recombinant cysteine depleted interferon-β muteins
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
GB2183661B
(en)
|
1985-03-30 |
1989-06-28 |
Marc Ballivet |
Method for obtaining dna, rna, peptides, polypeptides or proteins by means of a dna recombinant technique
|
|
US6492107B1
(en)
|
1986-11-20 |
2002-12-10 |
Stuart Kauffman |
Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
|
|
US4737456A
(en)
|
1985-05-09 |
1988-04-12 |
Syntex (U.S.A.) Inc. |
Reducing interference in ligand-receptor binding assays
|
|
US4938948A
(en)
|
1985-10-07 |
1990-07-03 |
Cetus Corporation |
Method for imaging breast tumors using labeled monoclonal anti-human breast cancer antibodies
|
|
US5618920A
(en)
|
1985-11-01 |
1997-04-08 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
|
DE3600905A1
(de)
|
1986-01-15 |
1987-07-16 |
Ant Nachrichtentech |
Verfahren zum dekodieren von binaersignalen sowie viterbi-dekoder und anwendungen
|
|
US5681718A
(en)
|
1986-03-14 |
1997-10-28 |
Celltech Limited |
Methods for enhanced production of tissue plasminogen activator in cell culture using alkanoic acids or salts thereof
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
WO1989006692A1
(en)
|
1988-01-12 |
1989-07-27 |
Genentech, Inc. |
Method of treating tumor cells by inhibiting growth factor receptor function
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US20040049014A1
(en)
|
1988-12-28 |
2004-03-11 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5108921A
(en)
|
1989-04-03 |
1992-04-28 |
Purdue Research Foundation |
Method for enhanced transmembrane transport of exogenous molecules
|
|
WO1990014443A1
(en)
|
1989-05-16 |
1990-11-29 |
Huse William D |
Co-expression of heteromeric receptors
|
|
CA2016842A1
(en)
|
1989-05-16 |
1990-11-16 |
Richard A. Lerner |
Method for tapping the immunological repertoire
|
|
CA2016841C
(en)
|
1989-05-16 |
1999-09-21 |
William D. Huse |
A method for producing polymers having a preselected activity
|
|
JPH049249A
(ja)
|
1990-04-27 |
1992-01-14 |
Kusuda:Kk |
塗型剤吹き付け機
|
|
US6916605B1
(en)
|
1990-07-10 |
2005-07-12 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
ATE300615T1
(de)
|
1990-08-29 |
2005-08-15 |
Genpharm Int |
Transgene mäuse fähig zur produktion heterologer antikörper
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
CA2405246A1
(en)
|
1990-12-03 |
1992-06-11 |
Genentech, Inc. |
Enrichment method for variant proteins with alterred binding properties
|
|
ES2341666T3
(es)
|
1991-12-02 |
2010-06-24 |
Medimmune Limited |
Produccion de autoanticuerpos de repertorios de segmentos de anticue rpos expresados en la superficie de fagos.
|
|
EP1291360A1
(en)
|
1991-12-13 |
2003-03-12 |
Xoma Corporation |
Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
|
|
EP1306095A3
(en)
|
1992-03-05 |
2003-06-25 |
Board Of Regents, The University Of Texas System |
Methods and compositions for targeting the vasculature of solid tumors
|
|
US5965132A
(en)
|
1992-03-05 |
1999-10-12 |
Board Of Regents, The University Of Texas System |
Methods and compositions for targeting the vasculature of solid tumors
|
|
US20030148406A1
(en)
|
1992-03-17 |
2003-08-07 |
David John King |
Multivalent antigen-binding proteins
|
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
|
AU691811B2
(en)
|
1993-06-16 |
1998-05-28 |
Celltech Therapeutics Limited |
Antibodies
|
|
US5432930A
(en)
|
1993-09-30 |
1995-07-11 |
Eagle Crest Limited |
System for accessing cobol data files by generating a dictionary of NF.sup.2
|
|
NL9302194A
(nl)
|
1993-12-15 |
1995-07-03 |
Nidera Handelscompagnie B V |
Werkwijze voor het bereiden van een samengevoegd visprodukt, alsmede visprodukt verkregen onder toepassing van deze werkwijze.
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
DE19526926A1
(de)
|
1995-07-24 |
1997-01-30 |
Bayer Ag |
Verfahren zur Herstellung beladener nichtporöser Trägermaterialien
|
|
US6696248B1
(en)
|
1995-08-18 |
2004-02-24 |
Morphosys Ag |
Protein/(poly)peptide libraries
|
|
AU725609C
(en)
|
1995-08-18 |
2002-01-03 |
Morphosys Ag |
Protein/(poly)peptide libraries
|
|
AU7378096A
(en)
|
1995-09-28 |
1997-04-17 |
Alexion Pharmaceuticals, Inc. |
Porcine cell interaction proteins
|
|
US5714352A
(en)
|
1996-03-20 |
1998-02-03 |
Xenotech Incorporated |
Directed switch-mediated DNA recombination
|
|
US6596850B1
(en)
|
1998-01-30 |
2003-07-22 |
Ixsys, Incorporated |
Anti-αv3β3 recombinant human antibodies, nucleic acids encoding same
|
|
WO2000023082A1
(en)
|
1998-10-19 |
2000-04-27 |
Yeda Research And Development Co. Ltd. |
Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens
|
|
US20040031072A1
(en)
|
1999-05-06 |
2004-02-12 |
La Rosa Thomas J. |
Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
|
|
ATE482275T1
(de)
|
1999-07-02 |
2010-10-15 |
Morphosys Ag |
Erzeugung spezifischer bindungspartner die an von genomischen dns-fragmenten oder ests kodierten (poly)peptiden binden
|
|
IT1307309B1
(it)
|
1999-12-30 |
2001-10-30 |
Enea Ente Nuove Tec |
Peptidi stabilizzanti, polipeptidi ed anticorpi che li comprendono.
|
|
PL211872B1
(pl)
|
2000-03-31 |
2012-07-31 |
Purdue Research Foundation |
Kompozycja farmaceutyczna
|
|
DE10037759A1
(de)
|
2000-08-03 |
2002-07-04 |
Gruenenthal Gmbh |
Screeningverfahren
|
|
MXPA03007316A
(es)
|
2001-02-19 |
2003-12-04 |
Merck Patent Gmbh |
Metodo para la identificacion de epitopes de celulas t y el uso para la preparacion de moleculas con inmunogenicidad reducida.
|
|
AU2002258518A1
(en)
|
2001-03-14 |
2002-09-24 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
|
|
CA2445826C
(en)
|
2001-05-02 |
2014-03-25 |
Purdue Research Foundation |
Treatment and diagnosis of macrophage mediated disease
|
|
US7314974B2
(en)
|
2002-02-21 |
2008-01-01 |
Monsanto Technology, Llc |
Expression of microbial proteins in plants for production of plants with improved properties
|
|
WO2003074704A1
(fr)
|
2002-03-01 |
2003-09-12 |
Japan Envirochemicals, Ltd. |
Proteines capables de se lier aux hormones sexuelles feminines et procede de preparation
|
|
CN1646160A
(zh)
*
|
2002-03-13 |
2005-07-27 |
拜奥根Idec马萨诸塞公司 |
抗αvβ6抗体
|
|
AU2003224073C1
(en)
|
2002-04-22 |
2010-03-11 |
AgroProtect GmbH |
Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi
|
|
GB0216648D0
(en)
|
2002-07-18 |
2002-08-28 |
Lonza Biologics Plc |
Method of expressing recombinant protein in CHO cells
|
|
CA2824167C
(en)
*
|
2002-09-06 |
2018-09-25 |
Amgen Inc. |
Therapeutic human anti-il-1r1 monoclonal antibody
|
|
WO2004043989A2
(en)
|
2002-11-07 |
2004-05-27 |
Medarex, Inc. |
Human monoclonal antibodies to heparanase
|
|
EP1481993A1
(en)
|
2003-05-28 |
2004-12-01 |
Xerion Pharmaceuticals AG |
Modulation of the poliovirus receptor function
|
|
WO2004082463A2
(en)
|
2003-03-17 |
2004-09-30 |
Medical College Of Ohio |
Folate receptor gene modulation for cancer diagnosis and therapy
|
|
US20050255114A1
(en)
|
2003-04-07 |
2005-11-17 |
Nuvelo, Inc. |
Methods and diagnosis for the treatment of preeclampsia
|
|
US20050025763A1
(en)
|
2003-05-08 |
2005-02-03 |
Protein Design Laboratories, Inc. |
Therapeutic use of anti-CS1 antibodies
|
|
CA2525251C
(en)
|
2003-05-09 |
2015-10-27 |
Duke University |
Cd20-specific antibodies and methods employing same
|
|
KR101424624B1
(ko)
|
2003-05-14 |
2014-07-31 |
이뮤노젠 아이엔씨 |
약물 콘쥬게이트 조성물
|
|
US7276497B2
(en)
|
2003-05-20 |
2007-10-02 |
Immunogen Inc. |
Cytotoxic agents comprising new maytansinoids
|
|
ZA200510282B
(en)
|
2003-07-02 |
2007-03-28 |
Genentech Inc |
Compositions and methods for the diagnosis and treatment of tumor
|
|
CA2548942C
(en)
|
2003-12-05 |
2013-10-15 |
Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health |
Anti-sars monoclonal antibodies
|
|
CA2556027C
(en)
|
2004-02-12 |
2015-11-24 |
Morphotek, Inc. |
Monoclonal antibodies that specifically block biological activity of a tumor antigen
|
|
WO2005075514A2
(en)
|
2004-03-10 |
2005-08-18 |
Lonza Ltd. |
Method for producing antibodies
|
|
CA2562833A1
(en)
|
2004-04-27 |
2005-11-03 |
Galapagos N.V. |
Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
|
|
US20080312425A1
(en)
|
2004-08-30 |
2008-12-18 |
Lonza Biologics Plc. |
Ion Exchange Chromatography and Purification of Antibodies
|
|
US7776869B2
(en)
|
2004-10-18 |
2010-08-17 |
Amgen Inc. |
Heteroaryl-substituted alkyne compounds and method of use
|
|
US7780963B2
(en)
|
2004-10-25 |
2010-08-24 |
Merck & Co., Inc. |
Anti-ADDL antibodies and uses thereof
|
|
AU2005337132B2
(en)
|
2004-12-21 |
2011-01-20 |
Monsanto Technology, Llc |
Transgenic plants with enhanced agronomic traits
|
|
US20090087478A1
(en)
|
2004-12-27 |
2009-04-02 |
Progenics Pharmaceuticals (Nevada), Inc. |
Orally Deliverable and Anti-Toxin Antibodies and Methods for Making and Using Them
|
|
BRPI0518994A2
(pt)
|
2004-12-31 |
2008-12-02 |
Biogen Idec Inc |
anticorpos ou polipeptÍdeos que se ligam a br3, seus usos e formulaÇÕes lÍquidas
|
|
US7700738B2
(en)
|
2005-01-27 |
2010-04-20 |
The Regents Of The University Of California |
Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
|
|
US7608413B1
(en)
|
2005-03-25 |
2009-10-27 |
Celera Corporation |
Kidney disease targets and uses thereof
|
|
AU2006230099B2
(en)
|
2005-03-25 |
2012-04-19 |
Gitr, Inc. |
GITR binding molecules and uses therefor
|
|
ATE460668T1
(de)
|
2005-03-30 |
2010-03-15 |
Purdue Research Foundation |
Verfahren zur prognose von brustkrebs mittels quantifizierung von zellulären folat vitamin rezeptoren
|
|
EP2172487A1
(en)
|
2005-04-22 |
2010-04-07 |
Morphotek Inc. |
Antibodies with Immune Effector Activity that Internalize in Folate Receptor Alpha-Positive Cells
|
|
US7786266B2
(en)
|
2005-05-12 |
2010-08-31 |
Oncotherapy Science, Inc. |
Methods for damaging cells using effector function of anti-DSC2 antibody
|
|
WO2006122822A2
(en)
|
2005-05-20 |
2006-11-23 |
Lonza Biologics Plc. |
High-level expression of recombinant antibody in a mammalian host cell
|
|
MX2007014673A
(es)
|
2005-05-24 |
2008-04-08 |
Avestha Gengraine Tech Pvt Ltd |
Metodo para la produccion de un anticuerpo monoclonal para cd20 para el tratamiento de linfoma de celular b.
|
|
US20070009434A1
(en)
|
2005-07-05 |
2007-01-11 |
Low Philip S |
Imaging and therapeutic method using monocytes
|
|
US7521195B1
(en)
|
2005-07-21 |
2009-04-21 |
Celera Corporation |
Lung disease targets and uses thereof
|
|
CA2619725C
(en)
|
2005-08-18 |
2016-06-07 |
Ramot At Tel Aviv University Ltd. |
Single chain antibodies against beta-amyloid peptide
|
|
JP4938263B2
(ja)
*
|
2005-08-19 |
2012-05-23 |
独立行政法人農業生物資源研究所 |
一本鎖抗体によるサイトゾルタンパク質の機能阻害法およびその利用
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
EP3190125A1
(en)
|
2005-08-31 |
2017-07-12 |
Merck Sharp & Dohme Corp. |
Engineered anti-il-23 antibodies
|
|
AU2006291990B2
(en)
|
2005-09-13 |
2012-05-31 |
National Research Council Of Canada |
Methods and compositions for modulating tumor cell activity
|
|
CA2625403A1
(en)
|
2005-10-17 |
2007-04-26 |
Institute For System Biology |
Tissue-and serum-derived glycoproteins and methods of their use
|
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
|
HRP20130494T1
(en)
|
2005-12-20 |
2013-08-31 |
Sbi Biotech Co., Ltd. |
Anti-ilt7 antibody
|
|
MX2008012023A
(es)
|
2006-03-21 |
2008-10-01 |
Wyeth Corp |
Metodos para prevenir y tratar enfermedades amiloidogenicas.
|
|
US8486412B2
(en)
|
2006-06-01 |
2013-07-16 |
Mayo Foundation For Medical Education And Research |
Immunity to folate receptors
|
|
CA2655933C
(en)
|
2006-06-23 |
2014-09-09 |
Alethia Biotherapeutics Inc. |
Polynucleotides and polypeptide sequences involved in cancer
|
|
US7910702B2
(en)
|
2006-07-28 |
2011-03-22 |
The Governors Of The University Of Alberta |
Recombinant antibodies to sclerotinia antigens
|
|
EP2520935A3
(en)
|
2006-08-09 |
2013-02-13 |
Homestead Clinical Corporation |
Organ-specific proteins and methods of their use
|
|
CA2914170C
(en)
*
|
2006-09-08 |
2018-10-30 |
Abbvie Bahamas Ltd. |
Interleukin-13 binding proteins
|
|
EP1900752A1
(en)
|
2006-09-15 |
2008-03-19 |
DOMPE' pha.r.ma s.p.a. |
Human anti-folate receptor alpha antibodies and antibody fragments for the radioimmunotherapy of ovarian carcinoma
|
|
MY162056A
(en)
|
2006-10-12 |
2017-05-31 |
Univ Tokyo |
Diagnosis and treatment of cancer using anti -ereg antibody
|
|
JP5632582B2
(ja)
|
2006-12-14 |
2014-11-26 |
中外製薬株式会社 |
抗Ｃｌａｕｄｉｎ３モノクローナル抗体およびそれを用いる癌の治療および診断
|
|
BRPI0720565A2
(pt)
|
2006-12-20 |
2013-09-17 |
Mmr Information Systems Inc |
anticorpos e mÉtodos para a sua preparaÇço e seu uso
|
|
US20080227704A1
(en)
|
2006-12-21 |
2008-09-18 |
Kamens Joanne S |
CXCL13 binding proteins
|
|
US7691980B2
(en)
|
2007-01-09 |
2010-04-06 |
Bio-Rad Laboratories, Inc. |
Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
|
|
EP2604284A1
(en)
|
2007-02-16 |
2013-06-19 |
KTB Tumorforschungsgesellschaft mbH |
Receptor And Antigen Targeted Prodrug
|
|
WO2008101231A2
(en)
|
2007-02-16 |
2008-08-21 |
Endocyte, Inc. |
Methods and compositions for treating and diagnosing kidney disease
|
|
EP2426145B1
(en)
*
|
2007-02-23 |
2017-01-18 |
Merck Sharp & Dohme Corp. |
Engineered anti-il-23p19 antibodies
|
|
US7915368B2
(en)
*
|
2007-05-23 |
2011-03-29 |
Bridgestone Corporation |
Method for making alkoxy-modified silsesquioxanes
|
|
WO2008145136A1
(en)
|
2007-05-30 |
2008-12-04 |
Aarhus Universitet |
Stat3 inactivation by inhibition of the folate receptor pathway
|
|
BRPI0812970A2
(pt)
|
2007-06-25 |
2019-09-24 |
Endocyte Inc |
conjugados contendo espaçadores hidrofílicos
|
|
CN101139613B
(zh)
|
2007-08-01 |
2011-06-08 |
姜荣锡 |
抗肿瘤二元多肽及其应用与制备方法
|
|
EP2231708B1
(en)
|
2007-12-12 |
2015-04-08 |
Pincell Srl |
Remedies for pemphigus containing anti-fas ligand antibodies
|
|
JP5660900B2
(ja)
|
2007-12-21 |
2015-01-28 |
ノバルティス アーゲー |
有機化合物
|
|
CN101918450A
(zh)
|
2008-01-11 |
2010-12-15 |
国立大学法人东京大学 |
抗cldn6抗体
|
|
EP2275431A3
(en)
|
2008-01-18 |
2011-05-25 |
Bio-Rad Laboratories, Inc. |
Enhanced fractionation of phosphorylated and nonphosphorylated biomolecules by apatite chromotography
|
|
JP5470817B2
(ja)
|
2008-03-10 |
2014-04-16 |
日産自動車株式会社 |
電池用電極およびこれを用いた電池、並びにその製造方法
|
|
WO2009132081A2
(en)
|
2008-04-24 |
2009-10-29 |
The Research Foundation Of State University Of New York |
Monoclonal antibody-based targeting of folate receptors
|
|
EP2276506A4
(en)
|
2008-04-30 |
2014-05-07 |
Immunogen Inc |
EFFICIENT CONJUGATES AND HYDROPHILIC BINDER
|
|
KR20200058590A
(ko)
|
2008-04-30 |
2020-05-27 |
이뮤노젠 아이엔씨 |
가교제 및 그 용도
|
|
US8383351B2
(en)
|
2008-06-11 |
2013-02-26 |
Oxford Brookes University |
Antibody to inhibin/ activin β-B subunit
|
|
AU2009293140A1
(en)
|
2008-09-17 |
2010-03-25 |
Endocyte, Inc. |
Folate receptor binding conjugates of antifolates
|
|
US20100092470A1
(en)
|
2008-09-22 |
2010-04-15 |
Icb International, Inc. |
Antibodies, analogs and uses thereof
|
|
CN101440130B
(zh)
|
2008-11-21 |
2011-07-27 |
中国人民解放军第四军医大学 |
一种抗人IL-13Rα2单克隆抗体的重链和轻链的可变区
|
|
WO2010080345A1
(en)
|
2008-12-19 |
2010-07-15 |
Graceway Pharmaceuticals, Llc |
Lower dosage strength imiquimod formulations and short dosing regimens for treating actinic keratosis
|
|
AU2010229924B2
(en)
|
2009-03-24 |
2016-07-21 |
Plus Therapeutics Inc. |
Devices and methods of cell capture and analysis
|
|
ES2624835T3
(es)
|
2009-08-06 |
2017-07-17 |
Immunas Pharma, Inc. |
Anticuerpos que se unen específicamente a los oligómeros A beta y uso de los mismos
|
|
WO2011042548A1
(en)
|
2009-10-09 |
2011-04-14 |
Sanofi-Aventis |
Polypeptides for binding to the "receptor for advanced glycation endproducts" as well as compositions and methods involving the same
|
|
TW201129383A
(en)
|
2010-02-10 |
2011-09-01 |
Immunogen Inc |
CD20 antibodies and uses thereof
|
|
CN103037900B
(zh)
|
2010-02-24 |
2016-04-06 |
伊缪诺金公司 |
叶酸受体1抗体与免疫缀合物以及其用途
|
|
AR080795A1
(es)
|
2010-03-24 |
2012-05-09 |
Genentech Inc |
Anticuerpos anti-lrp6 (proteina relacionada con el receptor ldl tipo 6)
|
|
US20120164137A1
(en)
|
2010-10-20 |
2012-06-28 |
Morphotek, Inc. |
Anti-folate receptor alpha antibody glycoforms
|
|
AU2011323124C1
(en)
|
2010-11-05 |
2016-09-22 |
Eisai Inc. |
Folate receptor alpha as a diagnostic and prognostic marker for folate receptor alpha-expressing cancers
|
|
MX2013011201A
(es)
|
2011-03-29 |
2013-12-16 |
Immunogen Inc |
Proceso para la elaboracion de conjugados de mejor homogeneidad.
|
|
RS58367B1
(sr)
|
2011-03-29 |
2019-03-29 |
Immunogen Inc |
Priprema konjugata antitela i majtanzinoida jednostepenim postupkom
|
|
IL281714B2
(en)
*
|
2011-04-01 |
2023-11-01 |
Immunogen Inc |
Methods for increasing the effectiveness of FOLR1 cancer therapy
|
|
US20120282282A1
(en)
|
2011-04-04 |
2012-11-08 |
Immunogen, Inc. |
Methods for Decreasing Ocular Toxicity of Antibody Drug Conjugates
|
|
WO2012145112A2
(en)
|
2011-04-18 |
2012-10-26 |
Immunogen, Inc. |
Novel maytansinoid derivatives with sulfoxide linker
|
|
EP2524929A1
(en)
|
2011-05-17 |
2012-11-21 |
Sanofi |
Use of anti-CD19 maytansinoid immunoconjugate antibody for the treatment of CD19+ B-cell malignancies syptoms
|
|
PL2731972T3
(pl)
|
2011-07-15 |
2018-06-29 |
Eisai R&D Management Co., Ltd. |
Przeciwciała skierowane przeciwko receptorowi folianowemu alfa i ich zastosowania
|
|
HUE049693T2
(hu)
|
2012-08-31 |
2020-10-28 |
Immunogen Inc |
Diagnosztikai ASSAY-k és készletek a folát receptor 1 kimutatására
|
|
WO2014055842A1
(en)
|
2012-10-04 |
2014-04-10 |
Immunogen, Inc. |
Process for preparing stable antibody maytansinoid conjugates
|
|
JP6136279B2
(ja)
|
2013-01-15 |
2017-05-31 |
株式会社ジェイテクト |
転がり軸受装置
|
|
TWI503850B
(zh)
|
2013-03-22 |
2015-10-11 |
Polytronics Technology Corp |
過電流保護元件
|
|
CA2911499A1
(en)
|
2013-05-14 |
2014-11-20 |
Immunogen, Inc. |
Anti-folr1 immunoconjugate dosing regimens
|
|
WO2015026909A2
(en)
|
2013-08-23 |
2015-02-26 |
Nuclea Biotechnologies, Inc. |
Msia-srm assay for biomarker analysis
|
|
AU2014312086B2
(en)
|
2013-08-30 |
2020-03-12 |
Immunogen, Inc. |
Antibodies and assays for detection of folate receptor 1
|
|
TWI510996B
(zh)
|
2013-10-03 |
2015-12-01 |
Acer Inc |
控制觸控面板的方法以及使用該方法的可攜式電腦
|
|
IL298044B2
(en)
|
2013-10-08 |
2024-11-01 |
Immunogen Inc |
Dosing regimens of anti-FOLR1 immunoconjugate
|
|
US20150297744A1
(en)
|
2014-03-28 |
2015-10-22 |
Immunogen, Inc. |
Anti-FOLR1 Immunoconjugate Dosing Regimens
|
|
CN107110840A
(zh)
|
2014-07-01 |
2017-08-29 |
爱科谱迅病理研究公司 |
针对化疗靶标的srm测定
|
|
CN106999604B
(zh)
|
2014-09-02 |
2021-08-03 |
伊缪诺金公司 |
用于配制抗体药物缀合物组合物的方法
|
|
AU2016323968B2
(en)
|
2015-09-17 |
2023-07-06 |
Immunogen, Inc. |
Therapeutic combinations comprising anti-FOLR1 immunoconjugates
|
|
ES2716900T3
(es)
|
2015-11-06 |
2019-06-17 |
Promise Advanced Proteomics |
Un método para cuantificar anticuerpos anti-TNF
|
|
US9816280B1
(en)
|
2016-11-02 |
2017-11-14 |
Matthew Reitnauer |
Portable floor
|
|
SG11202001348WA
(en)
|
2017-09-05 |
2020-03-30 |
Immunogen Inc |
Methods for detection of folate receptor 1 in a patient sample
|
|
JP2020534332A
(ja)
|
2017-09-22 |
2020-11-26 |
イミュノジェン， インコーポレイテッド |
カチオン交換クロマトグラフィーを使用した三重軽鎖抗体の分離
|
|
MA51629A
(fr)
|
2018-01-12 |
2020-11-18 |
Immunogen Inc |
Procédés de production, purification et formulation de conjugués anticorps-médicaments
|
|
WO2020223221A1
(en)
|
2019-04-29 |
2020-11-05 |
Immunogen, Inc. |
Biparatopic fr-alpha antibodies and immunoconjugates
|